Stanford researchers have developed potent protein Kinase inhibitors for inhibition of pathological activity of protein kinases involved in cell death, inflammation and cancer.
Stanford researchers developed a device that emits electromagnetic radiation that oscillates between at least first and second distinct polarization states.